A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox ...

JUPITER, FL - Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company with a market ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

Sleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, ...

In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...

A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, ...

A study by researchers at Ireland's Maynooth University showed that sleep problems are very common in people with Parkinson’s disease and such problems are associated with poorer quality of life in pa ...

Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...

Jupiter is actively exploring additional strategic partnerships to expand JOTROL’s application across other neuroinflammatory and metabolic disorders, including Alzheimer’s disease and longevity ...

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...